Nebivolol Accord (Nebivolol Hydrochloride)

Nebivolol Hydrochloride, the active ingredient in Nebivolol Accord, is a beta‑blocker presented as an oral tablet for oral use. It is used to treat hypertension and, where approved, heart failure in adult patients. GNH USA supplies Nebivolol Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nebivolol Accord is a selective β1‑adrenergic antagonist indicated for cardiovascular conditions that require blood‑pressure control and cardiac workload reduction. Hypertension: lowers systolic and diastolic blood pressure by reducing heart rate and peripheral vascular resistance. Heart failure: improves cardiac output and reduces symptoms by decreasing myocardial oxygen demand and after‑load.

Nebivolol Accord may cause a range of adverse reactions.

Common Side Effects: - Headache: mild to moderate pain often occurring early in therapy. - Dizziness: sensation of light‑headedness, especially upon standing. - Fatigue: generalized tiredness or reduced energy. - Bradycardia: slower than normal heart rate. - Nasal congestion: blocked or runny nose. - Diarrhea: loose stools occurring intermittently.

Serious or Rare Side Effects: - Severe bradycardia: markedly low heart rate requiring medical attention. - Symptomatic hypotension: significant drop in blood pressure causing faintness. - Heart block: impairment of electrical conduction in the heart. - Bronchospasm: narrowing of airways, particularly in patients with asthma. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Hepatic dysfunction: abnormal liver enzyme elevations.

Before initiating therapy, consider the following safety measures. Dose adjustment in renal impairment: reduce dose in patients with reduced kidney function. Caution in asthma or COPD: monitor for bronchospasm due to β‑blockade. Monitor heart rate and blood pressure: ensure values remain within therapeutic range. Avoid abrupt discontinuation: taper gradually to prevent rebound hypertension. Use with caution in diabetes: may mask hypoglycaemic symptoms. Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Nebivolol may interact with several drug classes, requiring clinical vigilance.

Major Interactions (Avoid): - Concomitant use with other beta‑blockers: additive cardiac depression. - Calcium channel blockers that affect AV node (e.g., verapamil, diltiazem): risk of severe bradycardia. - Strong CYP2D6 inhibitors (e.g., paroxetine, fluoxetine): increased nebivolol plasma levels.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance hypotensive effect. - ACE inhibitors or ARBs: additive blood‑pressure lowering. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may reduce antihypertensive efficacy.